← Leaderboards
Jean Christopher Chamcheu
Southern Univ A&M Col Baton Rouge
$880,629
Attributed
$880,629
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $619K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$880,629 · 2
By mechanism
P20$471,663 · 1
R15$408,966 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Design”
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Jeffrey Leintz · National Opinion Research Center$38,969,238
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Sabrina Paganoni · Massachusetts General Hospital$30,895,527
Research focus
DesignFisetinCellsCytotoxicityEnsureEquilibriumAnimal ModelCell LineCessation Of LifeChemotherapyAnalogEngineeringEnvironmentCancer CellAnti-Viral ResponseCancer EtiologyApoptosisCancer TypeAkt InhibitionCellular StressAdverse EffectsCell CycleCell DeathFrap1 Gene
Grant awards (3)
Development of natural and synthetic compounds as novel potentiators of HSV-1 VC2-GMCSF-based oncolytic viral therapy in Breast Cancer$261,663
P20 · FY2025 · GM · contact PI
Harnessing the potential of pharmacological small molecules to amplify VSV-based oncolytic viral therapy$408,966
R15 · FY2024 · CA · contact PI
Development of natural and synthetic compounds as novel potentiators of HSV-1 VC2-GMCSF-based oncolytic viral therapy in Breast Cancer$210,000
P20 · FY2024 · GM · contact PI